{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:48:10Z","timestamp":1781880490259,"version":"3.54.5"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006507","name":"Funda\u00e7\u00e3o Oswaldo Cruz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Spinal cord injury (SCI) is a serious condition that can lead to partial or complete paraplegia or tetraplegia. Currently, there are few therapeutic options for these conditions, which are mainly directed toward the acute phase, such as surgical intervention and high-dose steroid administration. Mesenchymal stromal cells (MSC) have been shown to improve neurological function following spinal cord injury. The aim of the study was to evaluate the safety, feasibility, and potential efficacy of MSC transplantation in patients with cervical traumatic SCI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We included seven subjects with chronic traumatic SCI (&amp;gt; 1 year) at the cervical level, classified as American Spinal Cord Injury Association impairment scale (AIS) grade A. Subjects received two doses of autologous bone marrow derived MSC, the first by direct injection into the lesion site after hemilaminectomy and the second three months later by intrathecal injection. Neurologic evaluation, spinal magnetic resonance imaging (MRI), urodynamics, and life quality questionnaires were assessed before and after treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Cell transplantation was safe without severe or moderate adverse effects, and the procedures were well tolerated. Neurological evaluation revealed discrete improvements in sensitivity below the lesion level, following treatment. Five subjects showed some degree of bilateral sensory improvement for both superficial and deep mechanical stimuli compared to the pretreatment profile. No significant alterations in bladder function were observed during this study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Transplantation of autologous MSC in patients with chronic cervical SCI is a safe and feasible procedure. Further studies are required to confirm the efficacy of this therapeutic approach.<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical trial registration<\/jats:title><jats:p><jats:ext-link>https:\/\/clinicaltrials.gov\/study\/NCT02574572<\/jats:ext-link>, identifier NCT02574572.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2024.1451297","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T04:44:22Z","timestamp":1726116262000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Transplantation of autologous mesenchymal stromal cells in complete cervical spinal cord injury: a pilot study"],"prefix":"10.3389","volume":"11","author":[{"given":"Carolina Th\u00e9","family":"Mac\u00eado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Solano","family":"de Freitas Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane Flora","family":"Villarreal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Nascimento","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00e1tia Nunes","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa Lima e Moura","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"da Silva Paix\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"da Rocha Bezerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f4nio Ol\u00edmpio","family":"da Silva Moura Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Santos","family":"Braz\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josildo Pereira","family":"Marins Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Costa","family":"Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Ribeiro","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena Botelho Pereira","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"key":"B1","article-title":"Traumatic spinal cord injury.","volume":"3","author":"Ahuja","year":"2017","journal-title":"Nat Rev Dis Prim."},{"key":"B2","article-title":"Steroids for acute spinal cord injury.","volume":"1","author":"Bracken","year":"2012","journal-title":"Cochrane Database Syst Rev."},{"key":"B3","doi-asserted-by":"crossref","DOI":"10.1016\/j.nec.2016.08.004","article-title":"Restorative treatments for spinal cord injury.","volume":"28","author":"Chen","year":"2017","journal-title":"Neurosurg Clin N Am."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1523\/JNEUROSCI.3174-09.2010","article-title":"Transplantation of ciliary neurotrophic factor-expressing adult oligodendrocyte precursor cells promotes remyelination and functional recovery after spinal cord injury.","volume":"30","author":"Cao","year":"2010","journal-title":"J Neurosci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1177\/1545968309347685","article-title":"Olfactory mucosal autografts and rehabilitation for chronic traumatic spinal cord injury.","volume":"24","author":"Lima","year":"2010","journal-title":"Neurorehabil Neural Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cne.20049","article-title":"Peripheral olfactory ensheathing cells reduce scar and cavity formation and promote regeneration after spinal cord injury.","volume":"473","author":"Ramer","year":"2004","journal-title":"J Comp Neurol."},{"key":"B7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21020659","article-title":"Stem cells therapy for spinal cord injury: An overview of clinical trials.","volume":"21","author":"Silvestro","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.brainres.2013.08.016","article-title":"Transplantation of autologous bone marrow mesenchymal stem cells in the treatment of complete and chronic cervical spinal cord injury.","volume":"1533","author":"Dai","year":"2013","journal-title":"Brain Res."},{"key":"B9","doi-asserted-by":"crossref","DOI":"10.3390\/cells11061019","article-title":"Clinical trials using mesenchymal stem cells for spinal cord injury: Challenges in generating evidence.","volume":"11","author":"de Ara\u00fajo","year":"2022","journal-title":"Cells."},{"key":"B10","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3727\/096368913X664540","article-title":"Autologous bone marrow-derived cell therapy combined with physical therapy induces functional improvement in chronic spinal cord injury patients.","volume":"23","author":"El-kheir","year":"2014","journal-title":"Cell Transplant."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.jcyt.2017.06.006","article-title":"Image-guided percutaneous intralesional administration of mesenchymal stromal cells in subjects with chronic complete spinal cord injury: A pilot study.","volume":"19","author":"Larocca","year":"2017","journal-title":"Cytotherapy."},{"key":"B12","doi-asserted-by":"crossref","DOI":"10.1186\/scrt516","article-title":"Safety and neurological assessments after autologous transplantation of bone marrow mesenchymal stem cells in subjects with chronic spinal cord injury.","volume":"5","author":"Mendonca","year":"2014","journal-title":"Stem Cell Res Ther."},{"key":"B13","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1590\/S0103-64402006000400012","article-title":"Adapted version of the McGill pain questionnaire to brazilian portuguese.","volume":"17","author":"Varoli","year":"2006","journal-title":"Braz Dent J."},{"key":"B14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0304-3959(75)90044-5","article-title":"The McGill pain questionnaire: Major properties and scoring methods.","volume":"1","author":"Melzack","year":"1975","journal-title":"Pain."},{"key":"B15","doi-asserted-by":"publisher","first-page":"395","DOI":"10.5966\/sctm.2013-0141","article-title":"Preliminary study of autologous bone marrow nucleated cells transplantation in children with spinal cord injury.","volume":"3","author":"Jarocha","year":"2014","journal-title":"Stem Cell Transl Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.jcyt.2016.05.003","article-title":"An approach to personalized cell therapy in chronic complete paraplegia: The Puerta de Hierro phase I\/II clinical trial.","volume":"18","author":"Vaquero","year":"2016","journal-title":"Cytotherapy."},{"key":"B17","doi-asserted-by":"crossref","DOI":"10.1186\/2001-1326-3-24","article-title":"Stem cell delivery of therapies for brain disorders.","volume":"3","author":"Aleynik","year":"2014","journal-title":"Clin Transl Med."},{"key":"B18","doi-asserted-by":"crossref","first-page":"8308","DOI":"10.1007\/s12035-016-0312-6","article-title":"Human mesenchymal stem cells from adipose tissue differentiated into neuronal or glial phenotype express different aquaporins.","volume":"54","author":"Avola","year":"2017","journal-title":"Mol Neurobiol."},{"key":"B19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells.","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science."},{"key":"B20","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-015-0240-9","article-title":"The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy.","volume":"6","author":"Zhang","year":"2015","journal-title":"Stem Cell Res Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1227\/NEU.0000000000001056","article-title":"A phase III clinical trial showing limited efficacy of autologous mesenchymal stem cell therapy for spinal cord injury.","volume":"78","author":"Oh","year":"2016","journal-title":"Neurosurgery."},{"key":"B22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jcyt.2016.12.002","article-title":"Repeated subarachnoid administrations of autologous mesenchymal stromal cells supported in autologous plasma improve quality of life in patients suffering incomplete spinal cord injury.","volume":"19","author":"Vaquero","year":"2017","journal-title":"Cytotherapy."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-019-1223-z","article-title":"IGF-1 overexpression improves mesenchymal stem cell survival and promotes neurological recovery after spinal cord injury.","volume":"10","author":"Allahdadi","year":"2019","journal-title":"Stem Cell Res Ther."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.883378","article-title":"Current status of mesenchymal stem\/stromal cells for treatment of neurological diseases.","volume":"15","author":"Soares","year":"2022","journal-title":"Front Mol Neurosci."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21041272","article-title":"Intrathecal injection in a rat model: A potential route to deliver human wharton\u2019s jelly-derived mesenchymal stem cells into the brain.","volume":"21","author":"Kim","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094858","article-title":"Exercise-induced plasticity in signaling pathways involved in motor recovery after spinal cord injury.","volume":"22","author":"Bilchak","year":"2021","journal-title":"Int J Mol Sci."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1451297\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T04:44:32Z","timestamp":1726116272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1451297\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":26,"alternative-id":["10.3389\/fmed.2024.1451297"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1451297","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,12]]},"article-number":"1451297"}}